Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S9–23. doi: 10.1016/j.jaci.2011.12.979

TABLE II.

Methods for measuring and reporting core and supplemental biomarker outcomes

Serologic multiallergen screen Preferred method: adults—Phadiatop; children— Phadiatop plus fx5 food allergen mix
Report as kUa/L (with 0.35 kUa/L as the cutpoint for presence of atopy)
Total serum IgE Preferred method: any FDA-cleared immunoassay
Allergen-specific IgE Preferred method: serum immunoassay
Preferred assay: ImmunoCAP (Phadia)
Alternative assays: HYTEC (Hycor) Immulite (Siemens)
Note: skin prick tests have no single generally accepted technique
Feno Preferred method: ATS/ERS guidelines13 for measurement at 50 L/s
Report whether online or offline method was used
Report as ppb in exhaled breath (<25 ppb indicates normal value)
Sputum eosinophils Preferred method: whole expectorate
Alternative method: sputum plug
Report as:
Preferred: eosinophil percentage per mL of sputum
Alternative: total eosinophils per μL of sputum
CBC (total eosinophils) Method: CBC by automated analyzer
Report as absolute eosinophil count (eosinophils × 109/L)
Percentage eosinophils is not recommended
Urinary LTE4 Preferred method: random urine sample; mass spectroscopy
Report as pg/μg creatinine (<50 pg/μg indicates normal value)